LGALS8 and non-small cell lung carcinoma: This finding is consistent with previous evidence that soluble galectin-8 inhibits cellular growth in the H1299 cell line (human non-small-cell lung carcinoma cells), by promoting the accumulation of the cyclin-dependent kinase inhibitor p21.